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Breast carcinoma has a complex subgross morphology in the majority of cases. The malignant transformation usually involves a
single breast lobe and may demonstrate peripheral, segmental, or lobar growth patterns in the in situ phase. During the invasive
phase, the tumor may grow beyond the borders of the aﬀected lobe. The dimensions of the involved lobe and the pattern of its
involvement determine the extent of the disease in the early phase, with the size, type, and position of the invasive foci being
additional determinants in more advanced cases. Breast carcinomas of limited extent (occupying a tissue area <40mm) are proper
candidates for breast-conserving surgery. In other cases, careful individual preoperative assessment of disease extent is necessary
in making decisions about the most appropriate surgical approach, taking into account the position of the lesion(s) within the
breast, the dimensions of the breast, and patient preference.
1.Introduction
Breast-conserving surgery completed with postoperative
irradiation results in good local control of the disease,
with relatively few ipsilateral local recurrences [1, 2]. A
considerable number of patients, however, still experience
local recurrence, even in some of the cases when the surgical
m a r g i n so ft h er e s e c t i o nh a v eb e e nj u d g e dt ob ec a n c e rf r e e .
This number is much higher if postoperative irradiation is
omitted [1, 2]. In addition to the possibility of erroneous
assessmentofthesurgicalmarginsasanexplanation,another
possibility istheleavingbehindoffociofcancerorrisktissue
within the breast after seemingly complete surgery [3].
Mostbreastcarcinomashaveacomplexmorphologythat
is often evident already at an early stage of the disease [3–8].
Early lesions are often nonpalpable, small, and hardly visible
to the naked eye. Nevertheless, despite their small size, early
breastcarcinomasareoftenmultifocalandextensive[4,8,9],
and the small individual foci may be spread over an area of
several centimeters in volume, resulting in a large extent of
the disease. These seemingly contradictory facts indicate the
need for using special nonfragmenting histology techniques
in all such cases and also emphasize the paramount impor-
tance of a detailed radiological-pathological correlation in
diagnosing breast carcinoma in the modern era.
Factorsinﬂuencingthesuccessofbreast-conservingther-
apy are numerous, with the ﬁnal determinants of treatment
choice being the extent of the disease, ability to tolerate
radiotherapy, and patient preference [10]. In this paper, the
subgrossmorphologyofbreastcancerisdiscussedinrelation
to the success of local control of the disease with a special
focus on disease extent.
2. Theoretical Background
Breast is a glandular organ with lobar morphology. A breast
lobe comprises a single lactiferous duct opening on the
nipple, its segmental, subsegmental, and terminal branches
with the terminal ductal-lobular units (TDLUs) at the end
of the branching tree. The reported number of lobes within
a mature breast varies considerably in the literature, 27
being the median in one detailed study [11]. The lobes are
individual units with no anastomotic connections between
them.
According to our hypothesis of the sick lobe [12–14],
breast carcinoma is a lobar disease in that the simultaneously
or asynchronously appearing in situ or invasive tumor foci
developwithinasinglesicklobeandthecancerousstructures
are conﬁned to the area of the sick lobe at the early stage of2 International Journal of Breast Cancer
the disease. The sick lobe probably contains more or more-
sensitive committed progenitor cells than the other lobes
of the same breast and is more sensitive to endogenous or
exogenous oncogenic stimuli. This hypothesis is congruent
with the concept of committed progenitor cells [15], as
well as with the concept of mammary ﬁeld cancerization
[16]. The most important implication of these concepts is
that an area several centimeters in size of genetically altered
tissue may exist in the breast and breast cancer develops
within this area rather than at one single point. According
to our related hypothesis, the theory of biological timing
[9, 13], the time of complete malignant transformation
of the committed progenitor cells, is determined by the
number of required additional genetic alterations, which
are mostly acquired during the division of these cells. This
transformation may appear in a single locus within the sick
lobe, at more than one locus at the same time or with
a considerable time diﬀerence, or at a large number of
loci leading to a unifocal, multifocal, or diﬀuse malignant
process,respectively.Althoughthevariationsinbreastcancer
morphology are practically unlimited, three patterns of
cancer development seem to be the most typical at the
early stage: the peripheral pattern (involving the TDLUs),
the segmental pattern (involving a segmental duct together
with its branches and terminal units), and the lobar pattern
(involving the entire sick lobe or large parts of it) [14].
Figure 1 illustrates these patterns for in situ carcinoma.
As demonstrated in numerous studies [17–19], further
mutations in the malignant cells and the cells of the sur-
roundingstromamayresultincancercellslosingtheirability
to maintain the myoepithelial layer and the basal membrane
around the ducts and terminal units, and the normal
periductal, intralobular, and interlobular stroma undergoes
remodeling. Both individual cancer cells and groups of such
cells may come into direct contact with stromal elements
and be entrapped in the remodeled stroma. They may
also come into contact with the prelymphatic spaces and
lymphatic vessels, invade them, and be transported via the
lymphatic spaces and lymphatic system within (or outside)
the breast. In this way, the invasive tumor may spread
beyond the area of the sick lobe. Through proliferation of
the malignant cells, the invasive component of the tumor
may grow, not only around the pre-existing in situ process
but also, following its intramammary spread, at distant sites.
The tumor foci may eventually coalesce, giving a larger
tumor mass with more complex morphology. By further
mutations and dediﬀerentiation, new cell clones may appear
intheinvasivefoci,leadingtointratumoralandintertumoral
heterogeneity within the same breast. Via these mechanisms,
the tumor gradually enters the advanced phase.
3. Assessing the SubgrossMorphology of
EarlyBreast Cancer
In our approach, the distributions of the invasive and in situ
components of the same cancer are determined separately.
In situ carcinomas are regarded as “unifocal” if they appear
to involve a single TDLU or several neighboring TDLUs
together with the belonging subsegmental or segmental
duct(s). They are designated as “multifocal” if they involve
several distant TDLUs with uninvolved breast tissue in
between and as “diﬀuse” if they involve mainly the larger
ducts [6–9]. The unifocal pattern of in situ carcinomas
corresponds to the segmental pattern, the multifocal pattern
to the peripheral pattern, and the diﬀuse to the lobar pattern
of cancer development, as discussed above and as illustrated
in Figure 1. These alternative terms reﬂect two approaches:
the peripheral-segmental-lobar designations reﬂecting the
biological approach based on the sick lobe hypothesis and
the unifocal-multifocal-diﬀuse designations reﬂecting the
practical routine diagnostic approach.
Invasive lesions are considered to be “unifocal” if only
one invasive focus is observed, which may or may not
contain an in situ component. “Multifocal” invasive lesions
arecharacterizedbythe presenceofmultiple, well-delineated
invasive tumor foci separated from each other by uninvolved
breast tissue, regardless of the distance between the foci.
Tumors dispersed over a large area in the section, much like
a spider web, with no distinct tumor mass are classiﬁed as
“diﬀuse,” but they are usually large and are not represented
among early cancers (Figure 2). Cancers may lack an in
situ or an invasive component although most of them have
both; any further combination of the in situ and invasive
components may characterize an individual case. Theoret-
ically, there are 16 such combinations [6]. In our practical
approach, however, after the initial separate assessment of
the distribution of the in situ and invasive foci, we combine
the ﬁndings so that diﬀuse distribution of the in situ or the
invasive component qualiﬁes the lesion as a tumor having a
diﬀuse combined lesion distribution. Multifocality of either
the in situ or invasive tumor component, or both, results in
multifocal combined lesion distribution.
Figure 3 demonstrates the percentages of diﬀerent
subgross tumor distribution (growth patterns) regarding
the in situ component, the invasive component, and the
combined patterns, respectively. The material comprises 565
consecutive cases newly diagnosed at our department, all
documented in large-format histology slides. Forty tumors
(7%, 40/565) lacked an in situ component, while 80/565
(14%) were purely in situ lesions lacking an invasive
component. A total of 25% (138/565) of in situ tumors were
diﬀuse (involving large parts of the ductal system of the sick
lobe), but only approximately 5% (26/565) of the tumors
showed the typical spider web-like diﬀuse pattern of the
invasive component. The in situ component was unifocal
in 33% (189/565) and multifocal in 35% (198/565), while
the invasive component was unifocal in half of the cases
(48%, 274/565) and multifocal in one third of cases (33%,
185/565). The combined distribution of the in situ and
the invasive components was as follows: unifocal in 37%
(209/565), multifocal in 35% (198/35), and diﬀuse in 28%
(158/565).
Thus, the subgross distribution of the lesion is complex
in the majority of breast carcinomas, and for its proper
assessment, a close and detailed radiologic-pathologic cor-
relation is as important as using adequate nonfragmenting
histology techniques. Assessment of lesion distribution is
essential because it represents independent morphologicInternational Journal of Breast Cancer 3
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Figure 1: The three basic growth patterns of in situ carcinoma within the sick breast lobe. Upper left: the peripheral pattern; upper right: the
segmental pattern; lower image: the lobar pattern. The structures involved by in situ carcinoma, corresponding to the extent of the disease,
are marked in the series of images on the right-hand side.
prognostic parameters in breast carcinoma, which are as
important as tumor size. Speciﬁcally, multifocal and diﬀuse
distribution of the invasive lesions is associated with an
increased propensity for metastatic tumor spreading [6–
8, 20, 21] and with shortened breast cancer-speciﬁc survival
[22–25].
4. The Extentof the Disease
While lesion distribution is often complex, disease extent
is a morphologic parameter that is easier to communicate
within the breast team. This parameter is deﬁned as the
area or volume of the breast tissue containing all the in
situ, invasive, and intravascular malignant tumor foci. Of
importance, disease extent and tumor size (deﬁned as the
largest dimension of the largest invasive tumor focus within
the breast) diﬀer from each other in the vast majority
of cases, being equal only in cases of unifocal invasive
carcinomashavingnoinsitucomponentoutsidetheinvasive
focus, which comprise no more than 15% of our cases.
Breast morphology as perceived in a histology specimen
reﬂectsthestatusofthebalancebetweendynamicprogressive
and regressive processes that were stopped at the moment
of tissue ﬁxation; it is a still frame from an ongoing
process. Microscopic analysis of the specimen gives us only
limited information about these processes but represents
an important checkpoint in the attempt to reconstruct the
natural history of a lesion. This reconstruction is particularly
valid for determining disease extent.
It has to be underlined that the extent of the disease
is a term relating not to a single component of the tumor,
but to all malignant structures within the same breast. The
parameter of extensive intraductal component (EIC) [26]
is not identical to disease extent. Using our approach, we
visualize malignant transformation of the large parts of the
ductal tree and/or the lobules within the sick lobe leading
to extensive disease in a considerable number of cases. This
situation represents a negative prognostic parameter [27],
similarly but not identically to that evidenced in cases with
EIC [26, 28].
4.1. Extent of the Disease: The Dimensions of the Involved
Breast Lobe. The dimensions of the breast lobes vary con-
siderably within the same breast and also individually. The
largest lobe demonstrated in one of the very few related
studies comprised 25% of the breast volume, the smallest
only 1% of the breast volume [29]. Lobes are larger in
the upper outer quadrant of the breast than in the medial
parts [30]. In addition, the dimensions of the lobes are
also age related; they are larger in younger women and
undergo involution around and after menopause. Lobes in
the medial quadrants of the breast develop later and undergo
involution earlier than the lobes in the lateral quadrants
[30]. During the malignant transformation of the structures
of the sick lobe, new cancerous TDLUs and ducts [27]
may develop and increase the dimension of the involved
lobe.
Young age strongly correlates with a high risk of local
recurrence after breast-conserving surgery, whether or not
radiotherapy is given [31]. This relationship is associated
with the dimensions of the sick lobe, which is an impor-
tant factor in determining the success of breast-conserving
surgery.
4.2. Extent of the Disease: The Biological Timing of Malignant
Transformation. The committed progenitor cells dispersed
unevenly within the sick lobe may undergo malignant trans-
formationundertheinﬂuenceofexogenousandendogenous4 International Journal of Breast Cancer
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Figure 2: The three basic growth patterns of invasive breast carcinoma. Upper left: unifocal; upper central: multifocal; upper right: diﬀuse
growth pattern. The extent of the disease is marked in the lower series of images.
oncogenicstimuli[15].Accordingtoourhypothesis,thetim-
ing of this transformation is determined by the number
of required genetic alterations, which are mostly acquired
during the division of these cells. This hypothesis has
been termed the hypothesis of biological timing. Malignant
transformation may appear in a single locus within the
sick lobe, more than one locus at the same time or with
considerable time diﬀerence, or at a large number of loci,
yielding the segmental, peripheral, and lobar patterns of
malignant transformation, respectively, as discussed above.
The timing and the pattern of malignant transformation
within the sick lobe are the main determinants of disease
extent, in addition to the dimensions of the lobe. Malignant
transformationmayappearinasmallsegmentofalargelobe,
giving rise to a unifocal early breast cancer of limited extent
(segmental pattern). Additional tumor foci may develop
within the same lobe years or decades later and will be
perceived as a local recurrence after the initial tumor has
been excised. If the malignant transformation targets distant
individual TDLUs (peripheral pattern), the process will be
multifocalfromitsbeginning.Theextentofsuchmalignancy
will be determined by the dimensions of the sick lobe and
the distance between the aﬀected TDLUs; the disease may
be extensive or of limited extent. Asynchronous involvement
of additional TDLUs leads to local recurrence if the sick
lobe was not completely removed by surgery. The lobar
pattern of malignant transformation develops as a result of
simultaneous alteration of the progenitor cells at many loci,
and,intheextreme,theentiretyofthesicklobe.Suchtumors
involve diﬀusely the larger ducts and many TDLUs within
the sick lobe. These tumors are often extensive from the very
beginning of their development (Figure 1). In one of our
studies, diﬀuse in situ carcinomas had an average disease
extent of 52.7mm (range 16–180mm) [32].
4.3. Extent of the Disease: Invasion beyond the Borders of
the Sick Lobe. Invasion may appear at a single locus or
(simultaneously or asynchronously) at several loci of the sickInternational Journal of Breast Cancer 5
Table 1: Ipsilateral local recurrence rates by disease extent and type of surgery: extensive tumors deﬁned as those occupying an area 4cm or
larger in the greatest dimension. Falun 1996–1998, 10-year followup.
Extensive tumors
≥4cm
Nonextensive tumors
<4cm Total Relative risk Signiﬁcance
level
Mastectomy 7.3% (9/124) 9.3% (8/86) 8.1% (17/210) RR = 0.7802
(CI: 0.3135–1.9429) P = .5937
Breast-conserving
surgery 20.5% (9/44) 7.4% (20/269) 8.9% (29/313) RR = 2.7511
(CI: 1.3401–5.6478) P = .0058
Sum 10.7% (18/168) 7.9% (28/355) 8.6% (46/523) RR = 1.3584
(CI: 0.7736–2.3852) P = .2862
Relative risk RR = 2.8182
(CI: 1.1955–6.6435)
RR = 1.2512
(CI: 0.5717–2.7380)
RR = 0.8737
(CI: 0.4928–1.5490)
Signiﬁcance level P = .0179 P = .5749 P = .6440
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Figure 3: Percentages of carcinomas with unifocal, multifocal,
and diﬀuse subgross patterns regarding the in situ component
of the tumor, the invasive component, or both combined. Falun
2008–2010.
lobe involved by an in situ cancer. The invasive component
may invade beyond the area of the sick lobe, especially in a
more advanced stage of the disease. Two mechanisms may
lead to the multifocality of the invasive component in breast
carcinoma:separate invasive foci may develop independently
from each other from in situ carcinoma in diﬀerent parts of
thesicklobe,ortheymaybearesultofintramammarytumor
spread via the (pre-)lymphatic system. The latter possibility
may explain the inﬂuence of multifocality on the metastatic
capacity of the tumors and on survival.
The rare diﬀuse invasive carcinomas develop simulta-
neously at many loci of the sick lobe and often invade
withoutprovokinganystromalreaction,whichinothercases
may limit the tumoral growth (Figure 2). The outcome is
an extensive invasive process involving large parts of the
breast and not conﬁned to the area of the sick lobe. Most
of these tumors are of the lobular type [33] and are large
and extensive at the moment of their clinical or radiological
detection. In one of our studies, these tumors had an average
size of 55.9mm (range 27–91mm) [32].
4.4. Extent of the Disease: Cutoﬀs. There is no international
consensus regarding the deﬁnition of extensive breast carci-
noma. Two cutoﬀs, 15mm and 40mm, are used in the Van
Nuys Prognostic Index scoring system [34], but this scoring
system is limited to cases of ductal carcinoma in situ. Faverly
et al. [5] deﬁned extensive carcinoma as tumors having
foci more than 1cm apart, in contrast to breast carcinomas
of limited extent, which were proposed by the authors as
adequate candidates for breast-conserving surgery. Because
the extent of the disease is deﬁned as volume or area of the
breasttissueincludingallthemalignantstructureswithinthe
breast, we prefer to use a cutoﬀ deﬁning the volume or the
area and not the distance between the foci.
We deﬁne extensive tumors as those occupying a tissue
area at least 40mm in the largest dimension in contrast to
breast carcinomas of limited extent [7, 9]. The most impor-
tant reason for choosing this cutoﬀ is the 10-year followup
results regarding our material (1996–1998), presented in
Tables 1, 2,a n d3.
Testing diﬀerent cutoﬀs (20mm, 30mm, and 40mm)
led to the conclusion that an extent of 40mm or more
represents the proper target cutoﬀ in selecting cases for
breast-conserving surgery. Such tumors comprised in our
materialonethirdofcarcinomasinthisseriesandexhibiteda
relative risk of 2.75 for developing ipsilateral local recurrence
compared to nonextensive tumors if treated with conserving
surgery and irradiation. Further, signiﬁcant diﬀerences were
seen in local ipsilateral recurrence rates when extensive
tumors treated with mastectomy versus breast-conserving
surgery were compared. Such statistically signiﬁcant diﬀer-
ences could not be demonstrated with 20-mm or 30-mm
cutoﬀ values. It is worth mentioning that an extent of the
disease greater or equal to 40mm also represents a survival-
related negative prognostic parameter [24, 25].
4.5. Extent of the Disease: Relation to Tumor Size. We
compared the extent of the disease and the distribution
of the lesions in a consecutive series of 120 purely in
situ carcinomas, 332 early invasive carcinomas (<15mm),
and 340 more advanced invasive carcinomas (≥15mm)
and found that the proportions of extensive cases in these
categories were 45.0%, 42.5%, and 42.4%, respectively [9].6 International Journal of Breast Cancer
Table 2: Ipsilateral local recurrence rates by disease extent and type of surgery: extensive tumors deﬁned as those occupying an area 3cm or
larger in the greatest dimension. Falun 1996–1998, 10-year followup.
Extensive tumors
≥3cm
Nonextensive tumors
<3cm Sum Relative risk Signiﬁcance
level
Mastectomy 7.5% (12/160) 10.0% (5/50) 8.1% (17/210) RR = 0.7500
(CI: 0.2776–2.0261) P = .5707
Breast-conserving
surgery 15.0% (12/80) 7.3% (17/233) 9.2% (29/313) RR = 2.0559
(CI: 1.0271–4.1152) P = .0418
Sum 10.0% (24/240) 7.8% (22/283) 8.8% (46/523) RR = 1.2864
(CI: 0.7404–2.2349) P = .3716
Relative risk RR = 2.0000
(CI: 0.9411–4.2502)
RR = 0.7296
(CI: 0.2824–1.8851)
RR = 1.1445
(CI: 0.6456–2.0291)
Signiﬁcance level P = .0715 P = .5151 P = .6440
Table 3: Ipsilateral local recurrence rates by disease extent and type of surgery: extensive tumors deﬁned as those occupying an area 2cm or
larger in the greatest dimension. Falun 1996–1998, 10-year followup.
Extensive tumors
≥2cm
Nonextensive tumors
<2cm Sum Relative risk Signiﬁcance
level
Mastectomy 7.7% (15/194) 12.5% (2/16) 8.1% (17/210) RR = 0.6186
(CI: 0.1549–2.4699) P = .4965
Breast-conserving
surgery 12.0% (18/150) 6.7% (11/163) 9.3% (29/313) RR = 1.7782
(CI: 0.8665–3.6407) P = .1154
Sum 9.6% (33/344) 7.3% (13/179) 8.8% (46/523) RR = 1.3209
(CI: 0.7135–2.4453) P = .3758
Relative risk RR = 1.5520
(CI: 0.8082–2.9766)
RR = 0.5399
(CI: 0.1310–2.2257)
RR = 1.1445
(CI: 0.6456–2.0291)
Signiﬁcance level P = .1859 P = .3937 P = .6440
In another study on carcinomas 1–14mm in size, we found
that 96 of 301 (31.9%) had a multifocal invasive component
and that none of them demonstrated a diﬀuse invasive
growthpattern[8].Thus,earlybreastcarcinomasareasoften
extensive and as often multifocal as their more advanced
counterparts; they diﬀer from the advanced carcinomas in
the smaller size of the individual invasive lesion(s).
4.6. Extent of the Disease: The Surrounding Normal Tissue.
Geneticalterationssimilaroridenticaltothoseincancermay
be found in morphologically normal breast tissue, a ﬁnding
stronglysupportingthesicklobehypothesis.Suchalterations
were demonstrated in normal-looking breast tissue as far as
4cmfromthecancerandeveninbreastsfreeofhistologically
veriﬁable cancer [14, 35]. Although the status of the surgical
margins is clearly related to the risk of developing local
recurrence, a clear margin, free of microscopic tumor foci,
is not a guarantee that already developed distant tumor foci
or a risk tissue carrying genetic abnormalities representing
potential source of cancer foci have not been left behind after
a seemingly complete intervention. Although postoperative
irradiation substantially reduces the risk of local recurrence
(Table 4), proper preoperative mapping of the disease and
identifying the sick lobe are essential in planning adequate
surgery.
The surgical intervention in early breast cancer must
target excision of the already developed and radiologically
and morphologically evident cancer foci together with the
surrounding genetically altered but morphologically normal
at-risk tissue. In other words, the aim is to remove the entire
sick lobe together with the lesions within it; partial excision
of the sick lobe represents a risk for tumor recurrence.
Because of the above-discussed morphological variability,
proper intravital mapping of the breast lobes and identifying
the borders of the sick lobe is very diﬃcult. Removing a
lobe-liketriangularpieceoftissuefromthebreast(segmental
excision)seemstobeamoreappropriateapproachincontext
of the sick lobe theory than a simple lumpectomy. Modern
breast ultrasound techniques may visualize the central axis
of a lobe and lead the radiologist and the surgeon to
excise the proper structures [30]. Figure 4 demonstrates a
case of breast carcinoma with a duct leading into the area
of the invasive tumor. Dooley propose routine operative
breast endoscopy during lumpectomy to direct the surgical
intervention towards the diseased part of the sick lobe [36];
his long experience with such an approach is reported in the
present issue of the International Journal of Breast Cancer.
Breast carcinomas of limited extent (occupying a tissue
area <40mm) are proper candidates for breast-conserving
surgery. In other cases, careful individual preoperativeInternational Journal of Breast Cancer 7
Table 4: Ipsilateral local recurrence rates by disease extent and postoperative irradiation in extensive tumors and tumors of limited extent
treated with breast-conserving surgery, Falun 1996–1998, 10-year followup.
Extent Irradiated Nonirradiated Data missing Sum Relative risk Signiﬁcance
level
≥4cm 10.7% (3/28) 42.9% (6/14) 0.0% (0/2) 20.5% (9/44) RR = 4.0000
(CI: 1.1709–13.6643) P = .0270
<4cm 3.9% (7/178) 15.2% (12/79) 50.0% (1/2) 7.4% (20/269) RR = 3.8626
(CI: 1.5803–9.2208) P = .0030
Figure 4: Invasive breast carcinoma with an in situ component
involving a lactiferous duct leading to the invasive area.
assessment of disease extent is necessary in making decisions
about the most appropriate surgical approach, taking into
account the position of the lesion(s) within the breast, the
dimensions of the breast, and patient preference.
5. Conclusions
Breast carcinoma is a lobar disease and, in the vast majority
of cases, it is conﬁned to the structures of a single sick
lobe at its early stage. Finding the ductal tree of the sick
lobe and mapping the diseased part(s) of it are essential in
guiding adequate surgical intervention. Breast carcinomas of
limited extent (<4cm), whether unifocal or multifocal, are
proper candidates for breast-conserving surgery. Adequacy
of breast conservation in more extensive tumors should be
carefully judged preoperatively in every individual case. In
situ carcinomas with a lobar growth pattern (diﬀuse ductal
carcinoma in situ) and invasive breast carcinomas of diﬀuse
type often represent extensive disease, limiting the success of
breast-conserving surgery.
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